Ellume Ltd (Ellume) is a health technology company. The company operates in quantum dot based diagnostics to enable real-time detection of common conditions including influenza, strep throat and chlamydia. It develops ellume lab, a versatile and convenient diagnostic device that complements a doctor’s decision-making and allows for accurate and real-time near-patient testing in a doctor’s office. Ellume also provides quantum dot fluorescent nanoparticles, fluorescent immunoassay reader and technology integration services. It developd technology such as patended platform technology, digital connectivity and real-time reporting and others.. The company offers medical diagnostic products to healthcare markets. Ellume is headquartered in East Brisbane, Queensland, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Ellume Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Ellume Ltd Company Overview
Ellume Ltd Company Snapshot
Ellume Ltd Pipeline Products and Ongoing Clinical Trials Overview
Ellume Ltd – Pipeline Analysis Overview
Ellume Ltd - Key Facts
Ellume Ltd - Major Products and Services
Ellume Ltd Pipeline Products by Development Stage
Ellume Ltd Pipeline Products Overview
Ellume Respirio Flu Test
Ellume Respirio Flu Test Product Overview
ellume.lab - Influenza A+B / RSV
ellume.lab - Influenza A+B / RSV Product Overview
ellume·lab
ellume·lab Product Overview
ESP-Based Diagnostic Test - Chlamydia
ESP-Based Diagnostic Test - Chlamydia Product Overview
ESP-Based Diagnostic Test - Gonorrhoea
ESP-Based Diagnostic Test - Gonorrhoea Product Overview
ESP-Based Diagnostic Test - Group A Streptococci
ESP-Based Diagnostic Test - Group A Streptococci Product Overview
ESP-Based Diagnostic Test - Malaria
ESP-Based Diagnostic Test - Malaria Product Overview
ESP-Based Diagnostic Test - Pregnancy
ESP-Based Diagnostic Test - Pregnancy Product Overview
Point of Care Flu-COVID Combination Diagnostic Test
Point of Care Flu-COVID Combination Diagnostic Test Product Overview
Smart Phone Enabled Device
Smart Phone Enabled Device Product Overview
Ellume Ltd - Key Competitors
Ellume Ltd - Key Employees
Ellume Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Ellume Ltd, Recent Developments
Jul 14, 2022: Ellume COVID-19 Home Test now available through covid.gov/tests for blind and low-vision people
Dec 13, 2021: Ellume COVID-19 Home Test to allow users to send results directly to healthcare providers
Dec 03, 2021: Emerging omicron variant reinforces the role of rapid antigen testing
Nov 10, 2021: Ellume recalls COVID-19 home test for potential false positive SARS-CoV-2 test results
Oct 08, 2021: Coronavirus (COVID-19) update: October 8, 2021
Oct 06, 2021: Ellume recalls 200,000 Covid-19 test kits over false positives
Oct 05, 2021: Potential for false positive results with certain lots of Ellume COVID-19 home tests due to a manufacturing issue: FDA safety communication
May 10, 2021: Ellume establishes flagship U.S. manufacturing facility in Maryland
Mar 10, 2021: Ellume and Cambridge Consultants collaborate on Core Technology behind Ellume’s Rapid Antigen COVID-19 Test
Feb 01, 2021: Ellume announces $231.8 million agreement with the U.S. government